Source: http://www.google.es/patents/US9040111
Timestamp: 2017-11-23 22:41:32
Document Index: 53834442

Matched Legal Cases: ['Application No. 201010267157', 'Application No. 201010267157', 'Application No. 201010267157', 'Application No. 201010267157', 'Application No. 200880105243', 'Application No. 201010267157', 'Application No. 20080105243', 'Application No. 08829751', 'Application No. 10164082', 'Application No. 08829751', 'Application No. 2010', 'Application No. 2009', 'Application No. 2013', 'Application No. 2013', 'Application No. 2013', 'Application No. 2011', 'Application No. 10', 'Application No. 10']

Patente US9040111 - Method of making a stent - Google Patentes
A method of making a stent, including preparing a solution containing a composition, the composition comprising a biodegradable polymer and a vascular intimal hyperplasia inhibitor of a kind, including argatroban, which does not inhibit proliferation of endothelial cells, the weight compositional ratio...http://www.google.es/patents/US9040111?utm_source=gb-gplus-sharePatente US9040111 - Method of making a stent
Número de publicación US9040111 B2
Número de solicitud US 13/729,630
También publicado como CN101795719A, CN101795719B, CN101940802A, CN101940802B, EP2201966A1, EP2201966A4, EP2258414A2, EP2258414A3, US8409272, US8641756, US8968392, US20100198344, US20100249914, US20120310329, US20130018455, US20130115363, WO2009031295A1
Número de publicación 13729630, 729630, US 9040111 B2, US 9040111B2, US-B2-9040111, US9040111 B2, US9040111B2
Citas de patentes (64), Otras citas (44), Clasificaciones (28)
US 9040111 B2
US20020168393 * 2 May 2002 14 Nov 2002 Ryota Sugimoto Implantable medical material and implantable medical device
US20050015136 16 Oct 2002 20 Ene 2005 Ken Ikeuchi Stent
US20090005862 15 Ene 2007 1 Ene 2009 Tatsuyuki Nakatani Stent and Method For Fabricating the Same
US20100249914 2 Jun 2010 30 Sep 2010 Japan Stent Technology Co., Ltd. Sustained drug-releasing stent
US20110060403 15 Ene 2007 10 Mar 2011 Tatsuyuki Nakatani Stent and Method For Fabricating the Same
JP3605388B2 Título no disponible
JP3654627B2 Título no disponible
JP2004526499A Título no disponible
JP2005530551A Título no disponible
JP2005534724A Título no disponible
JP2007195883A Título no disponible
JP2007215620A Título no disponible
JP2007229123A Título no disponible
JP2008179788A Título no disponible
JP2008523901A Título no disponible
JPH03605388A Título no disponible
JPH03654627A Título no disponible
JPH11500047A Título no disponible
WO2007047473A2 12 Oct 2006 26 Abr 2007 Abbott Laboratories Methods of administering rapamycin analogs with anti-inflammatories using medical devices
WO2007086269A1 15 Ene 2007 2 Ago 2007 Toyo Advanced Technologies Co., Ltd. Stent and process for producing the same
WO2007148714A1 20 Jun 2007 27 Dic 2007 Kaneka Corporation Implant using rifamycin derivative
WO2009031295A1 3 Sep 2008 12 Mar 2009 Japan Stent Technology Co., Ltd. Stent for controlled drug release
4 Chinese Office Action issued Mar. 26, 2014 in corresponding Chinese Patent Application No. 201010267157.2.
5 Chinese Office Action issued Nov. 29, 2012 in corresponding Chinese Patent Application No. 201010267157.2.
6 Chinese Office Action issued Nov. 29, 2012, in corresponding Chinese Patent Application No. 201010267157.2.
7 Chinese Office Action mailed Apr. 7, 2013 in corresponding Chinese Application No. 201010267157.2.
8 Chinese Office Action mailed Mar. 22, 2013 in corresponding Chinese Application No. 200880105243.4.
9 Chinese Office Action mailed Oct. 17, 2013 in a related Chinese Patent Application No. 201010267157.2.
10 Chinese Office Action mailed Oct. 8, 2013 in a related Chinese Patent Application No. 20080105243.4.
11 Communication mailed Dec. 6, 2012, issued in corresponding U.S. Appl. No. 12/733,460.
12 Communication mailed Jan. 11, 2012, issued in corresponding U.S. Appl. No. 12/733,460.
13 English Translation of the International Preliminary Report on Patentability mailed Apr. 8, 2010 in corresponding International Patent Application PCT/JP2008/002410.
14 European Office Action issued May 21, 2014 in corresponding European Patent Application No. 08829751.0.
15 Extended European Search Report issued Jul. 30, 2014 in related European Patent Application No. 10164082.9.
16 Extended European Search Report issued May 24, 2013 in related European Application No. 08829751.0.
17 International Search Report for PCT/JP2008/002410, mailed Oct. 7, 2008.
18 Japanese Notification of Reasons for Rejection mailed Dec. 11, 2012, issued in corresponding Japanese Patent Application No. 2010-134943.
19 Japanese Office Action issued May 21, 2013 in related Japanese Application No. 2009-531112.
20 Japanese Office Action issued Sep. 30, 2014 in related Japanese Patent Application No. 2013-021872.
21 Japanese Office Action mailed Feb. 4, 2014 in corresponding Japanese Application No. 2013-021872.
22 Japanese Office Action mailed Feb. 4, 2014 in corresponding Japanese Application No. 2013-021873.
23 Japanese Office Action mailed Nov. 12, 2013 in a related Japanese Patent Application No. 2011-502731.
24 Kayla L. Metzger et al., Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits, Psychlpharmacology, DOI 10.1007/s0023-006-0616-8, Received: May 31, 2006/Accepted: Oct. 13, 2006 © Springer-Verlag 2006, pp. 1-11.
25 Korean Office Action issued Aug. 22, 2014 in related Korean Patent Application No. 10-2010-7007202.
26 Korean Office Action issued Aug. 28, 2014 in related Korean Patent Application No. 10-2010-7013253.
27 Leila Mureebe et al, "Inhibition of Intimal Hyperplasia by Direct Thrombin Inhibitors in an Animal Vein Bypass Model", Annals of Vascular Surgery, Aug. 2004, pp. 147-150.
28 Notice Allowance mailed Sep. 6, 2012, issued in corresponding U.S. Appl. No. 12/733,460.
29 Notice of Allowance mailed from the United States Patent and Trademark Office on Jul. 24, 2013 in U.S. Appl. No. 13/137,560.
30 Notice of Allowance mailed from the United States Patent and Trademark Office on Sep. 30, 2013 in U.S. Appl. No. 13/492,290.
31 Office Action mailed Sep. 30, 2011, issued in corresponding U.S. Appl. No. 12/733,460.
32 Restriction Requirement mailed Apr. 19, 2012, issued in corresponding U.S. Appl. No. 12/733,460.
33 U.S. Appl. No. 12/733,460, filed Mar. 3, 2010, Ikuo Omura et al.
34 U.S. Appl. No. 12/733,460, filed Mar. 3, 2010, Ikuo Omura et al., Japan Stent Technology Co., Ltd., Tokai University Educational System, Toyo Advanced Technologies Co., Ltd. and Hiroo Iwata of Kyoto-Shi, Japan.
35 U.S. Appl. No. 12/801,307, filed Jun. 2, 2010, Ikuo Omura et al., Abandoned.
36 U.S. Appl. No. 12/801,307, filed Jun. 2, 2010, Ikuo Omura et al., Japan Stent Technology Co., Ltd., Tokai University Educational System, and Hiroo Iwata of Kyoto-Shi, Japan, (Abandoned).
37 U.S. Appl. No. 13/137,560, filed Aug. 25, 2011, Ikuo Omura et al, Japan Stent Technology Co., Ltd.
38 U.S. Appl. No. 13/492,290, filed Jun. 8, 2012, Ikuo Omura et al.
39 U.S. Appl. No. 13/492,290, filed Jun. 8, 2012, Ikuo Omura et al., Japan Stent Technology Co., Ltd., Tokai University Educational System, Toyo Advanced Technologies Co., Ltd. and Hiroo Iwata of Kyoto-Shi, Japan.
40 U.S. Appl. No. 13/561,828, filed Jul. 27, 2012, Ikuo Omura et al.
41 U.S. Appl. No. 13/561,828, filed Jul. 27, 2012, Ikuo Omura et al., Japan Stent Technology Co., Ltd., Tokai University Educational System, Toyo Advanced Technologies Co., Ltd. and Hiroo Iwata of Kyoto-Shi, Japan.
42 U.S. Notice of Allowance mailed Sep. 6, 2012, issued in parent U.S. Appl. No. 12/733,460.
43 U.S. Office Action mailed Feb. 27, 2013 in U.S. Appl. No. 13/137,560.
44 U.S. Office Action mailed May 17, 2013 in U.S. Appl. No. 13/492,290.
Clasificación de EE.UU. 427/2.25, 424/424, 623/1.46, 424/423, 427/2.24
Clasificación internacional A61L31/10, A61P9/14, A61F2/915, A61F2/82, A61F2/91, A61K9/00, A61L31/00, A61M29/02, A61K38/55, A61F2/00, A61L31/16, A61L33/00
Clasificación cooperativa A61F2/915, A61F2002/91541, A61L31/16, A61L31/10, A61F2/91, A61K9/0024, A61F2250/0067, A61F2/82, A61L2300/608, A61L2300/416, A61L2420/08